Paytm shares slide 7.7% after Q2 results as revenue declines and one-time gain helps profit

One97 Communication, the parent firm of Paytm, fell as much as 7.7% to an intra-day low of Rs 669.80. The company reported a net profit of Rs 930 crore in the second quarter of FY25 against a loss of Rs 290 crore posted in the same quarter a year ago.

However, the company’s revenue from operations declined by 34% on year to Rs 1,659 crore in Q2 FY25 compared to Rs 1,095 crore in Q2 FY24. The gain in net profit can be attributed to the sale of the ticketing business to Zomato. 

If the sale of the ticketing business is kept aside then it is still a loss-making company of Rs 495 crore for the reporting quarter. The loss has widened by 70% compared to the previous fiscal year. 

Paytm’s Q1 performance

The company recorded a consolidated net loss of Rs 839 crore in Q1 FY25 widened from Rs 357 crore in Q1 FY24. Its revenue from operations stood at Rs 1,502 crore in the previous quarter of FY25 declining from Rs 2,342 crore in Q1 FY24. 

RBI cracked whip on Paytm

In March 2024, the lender of last resort cracked its whip on the company over irregularities in KYC (know your customer) norms, compliance issues, and related party transactions. The RBI was concerned regarding money laundering and questionable transactions involving crores of rupees. 

Also ReadPaytm swings back to profit at Rs 928.30 crore on gains from ticketing business sale, revenue drops by 34.1% YoY

Paytm Vs Nifty 50

Paytm stock has fallen 4.3% in the last five trading sessions. However, it has given a 7% return in the past one month and 84% in the last six months. From year to date, the stock has given 8%. However, it erased 25% of the wealth in the last one year. 

To compare, the benchmark index Nifty 50 has fallen 1.7% in the last five trading sessions. It has fallen more than 5% in the past one month. However, the index is still in the green, giving a 10% return in the last six months. It has risen 13% from year to date and 28% in the last one year. 

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth